Trading Halt
Open PDF
| Stock | Syntara Ltd (SNT.ASX) |
|---|---|
| Release Time | 3 Jul 2026, 9:23 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Syntara Ltd Trading Halt Pending iRBD Study Results
Key Points
- Trading halt requested by Syntara Ltd pending announcement of iRBD Parkinson's study results
- Halt will remain until preliminary results are released or trading resumes on 6 July 2026
- Company confirms no undisclosed reasons against granting the halt
Full Summary
Syntara Limited (ASX: SNT) has requested a trading halt on its securities to prevent trading until the announcement of preliminary results from the iRBD Parkinson's disease study of SNT-4728. The halt will remain in effect until the earlier of the release of the announcement or the commencement of trading on 6 July 2026. The company confirms it is not aware of any reasons why the trading halt should not be granted.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In